Plant Compound Prevents Brain Bleeding and Cell Death

Greg Howard
31st May, 2024

Plant Compound Prevents Brain Bleeding and Cell Death

Salvianolic acid A (SAA) protects primary cortical neurons from hemin-induced ferroptosis by reducing key markers of oxidative stress (a–b, d–e) while restoring crucial antioxidant defenses and protective proteins (c, f–h).

Image adapted from: Shi et al. / CC BY (Source)

Key Findings

  • Researchers at Hebei Medical University found that Salvianolic Acid A (SAA) can reduce brain damage after intracerebral hemorrhage (ICH) in rats
  • SAA works by inhibiting ferroptosis, a type of cell death caused by iron and oxidative stress, which is a major factor in brain injury post-ICH
  • The study showed that SAA activates the Akt/GSK-3β/Nrf2 signaling pathway, enhancing the brain's antioxidant defenses and reducing iron-induced damage
Intracerebral hemorrhage (ICH) is a severe type of stroke characterized by bleeding within the brain, leading to high rates of disability and mortality. Recent research has pointed to ferroptosis, a regulated form of cell death dependent on iron, as a critical factor in neuronal damage following hemorrhagic stroke[1]. Ferroptosis involves the accumulation of iron-induced reactive oxygen species (ROS) and lipid peroxidation, which culminates in cell death. This process has been previously highlighted as a significant contributor to neuronal death and secondary brain injury post-ICH[2]. In a study conducted by Hebei Medical University, researchers explored the therapeutic potential of Salvianolic Acid A (SAA), a natural polyphenol compound known for its anti-inflammatory, antioxidant, and antifibrosis properties, in mitigating ferroptosis-mediated neuronal damage after ICH. The study aimed to evaluate the efficacy of SAA in inhibiting ferroptosis and to elucidate the underlying mechanisms. The researchers constructed both in vivo (within a living organism) and in vitro (outside a living organism, in an artificial environment) models of ICH in rats. They administered SAA at doses of 10 mg/kg in vivo and 50 μM in vitro, observing significant alleviation of dyskinesia (movement disorders) and brain injury in the ICH models. This improvement was linked to the inhibition of ferroptosis, as evidenced by reduced lipid peroxidation and iron accumulation in the affected brain regions. To understand the mechanisms by which SAA exerts its neuroprotective effects, the researchers utilized network pharmacology, which combines computational and experimental methods to identify potential drug targets and mechanisms. They constructed a network of protein-protein interactions (PPIs) to pinpoint specific targets of SAA in the context of ICH. Molecular docking and functional enrichment analyses suggested that the AKT (V-akt murine thymoma viral oncogene homolog) signaling pathway could mediate the effects of SAA, with NRF2 (Nuclear factor erythroid 2-related factor 2) identified as a potential target. Further experiments demonstrated that SAA enhanced the activation of the Akt/GSK-3β/Nrf2 signaling pathway both in vivo and in vitro. This pathway is crucial for regulating oxidative stress and cell survival. Specifically, SAA increased the expression of GPX4 and XCT proteins, which are key players in the antioxidant defense system, and promoted the nuclear expression of Nrf2. The activation of these proteins helps to counteract the oxidative damage induced by iron overload, thus inhibiting ferroptosis. The study's findings align with earlier research that identified ferroptosis as a significant contributor to neuronal death following ICH and highlighted the potential of iron chelation therapy in mitigating this process[2]. Moreover, the identification of SAA as an effective inhibitor of ferroptosis expands on previous work that underscored the importance of targeting lipid peroxidation and ROS in treating ICH[3][4]. In summary, this study from Hebei Medical University provides compelling evidence that SAA can effectively ameliorate ICH-mediated neuronal ferroptosis by activating the Akt/GSK-3β/Nrf2 signaling pathway. These findings offer a promising avenue for developing new therapeutic strategies to treat ICH and potentially other conditions where ferroptosis plays a critical role.

MedicineHealthBiochem

References

Main Study

1) Salvianolic acid A inhibits ferroptosis and protects against intracerebral hemorrhage.

Published 30th May, 2024

https://doi.org/10.1038/s41598-024-63277-4

Related Studies

2) Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage.

https://doi.org/10.1136/svn-2018-000205

3) Ferroptosis: an iron-dependent form of nonapoptotic cell death.

https://doi.org/10.1016/j.cell.2012.03.042

4) Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.

https://doi.org/10.1016/j.cell.2017.09.021


Related Articles

An unhandled error has occurred. Reload 🗙